Company Filing History:
1 out of 2,009 
1 out of 832,761 Years Active: 2003-2019
Title: **L Kristin Newby: Innovator in Cardiovascular Risk Assessment**
Introduction
L Kristin Newby, based in Durham, NC, is a prominent inventor with contributions that significantly enhance our understanding of cardiovascular health. With a total of two patents to her name, Newby's work focuses on innovative methods for assessing and predicting cardiovascular disease risks, which are crucial in clinical settings.
Latest Patents
Newby's latest patents delve into the intricate mechanisms of cardiovascular health. One patent is centered around predicting coronary artery disease and risks of cardiovascular events. This patent discloses methods to assess the risk of cardiovascular disease by detecting levels of specific metabolites in a subject's sample. Key metabolites highlighted include acylcarnitines, amino acids, ketones, free fatty acids, and hydroxybutyrate. These metabolites can indicate the subject's risk of coronary artery disease as well as the potential for cardiovascular events.
Another significant patent focuses on evaluating therapies and predicting clinical outcomes for patients who have undergone treatment for acute coronary syndromes, such as myocardial infarction. This innovative method involves detecting multiple serum creatine kinase-MB release curve variables, which help predict the patient’s clinical outcome post-therapy. This research holds particular importance in conjunction with established therapies like thrombolytic therapy and serves as a valuable surrogate endpoint in clinical trials for emerging therapies.
Career Highlights
L Kristin Newby has had an impactful career, contributing her expertise in cardiovascular research while working with esteemed institutions such as Duke University. Her role in such a prestigious institution underscores her commitment to advancing medical science and patient care.
Collaborations
Throughout her career, Newby has collaborated with notable professionals in her field, including Robert H Christenson and Show-Hong Duh. These collaborations reflect a commitment to fostering innovation and improving methodologies in cardiovascular disease assessment.
Conclusion
L Kristin Newby stands out as a key inventor in the realm of cardiovascular health. Her pioneering patents provide critical insights that have the potential to transform patient outcomes through enhanced risk assessment and therapeutic evaluation. As the understanding of cardiovascular diseases evolves, innovators like Newby remain at the forefront, paving the way for advancements that could save lives.